Two Sigma Advisers
CDTX

Two Sigma Advisers’s Cidara Therapeutics CDTX Stock Holding History

Two Sigma Advisers’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,195
Closed -$22K – 2467
2024
Q1 		$22K Sell
1,195
-825
-41% -$11.8K ﹤0.01% 2397
2023
Q4 		$32.1K Sell
2,020
-740
-27% -$11.9K ﹤0.01% 2427
2023
Q3 		$52K Sell
2,760
-1,070
-28% -$21K ﹤0.01% 2273
2023
Q2 		$86.6K Buy
3,830
+650
+20% +$15.3K ﹤0.01% 2229
2023
Q1 		$80.8K Buy
3,180
+1,890
+147% +$53.6K ﹤0.01% 2406
2022
Q4 		$19.5K Sell
1,290
-120
-9% -$1.43K ﹤0.01% 2431
2022
Q3 		$18K Sell
1,410
-525
-27% -$7.25K ﹤0.01% 2446
2022
Q2 		$19K Sell
1,935
-5,785
-75% -$71.5K ﹤0.01% 2552
2022
Q1 		$129K Sell
7,720
-19,595
-72% -$332K ﹤0.01% 2463
2021
Q4 		$694K Buy
27,315
+3,885
+17% +$121K ﹤0.01% 1748
2021
Q3 		$1.05M Buy
23,430
+21,400
+1,054% +$813K ﹤0.01% 1598
2021
Q2 		$82K Sell
2,030
-2,410
-54% -$102K ﹤0.01% 2358
2021
Q1 		$236K Buy
4,440
+2,707
+156% +$134K ﹤0.01% 2304
2020
Q4 		$69K Sell
1,733
-837
-33% -$41.6K ﹤0.01% 2297
2020
Q3 		$146K Sell
2,570
-1,813
-41% -$128K ﹤0.01% 2221
2020
Q2 		$323K Buy
4,383
+2,540
+138% +$165K ﹤0.01% 2095
2020
Q1 		$91K Buy
1,843
+1,143
+163% +$68.5K ﹤0.01% 2309
2019
Q4 		$54K Buy
+700
New +$32K ﹤0.01% 2290

Other funds holding CDTX

MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $390M AUM 96.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Two Sigma Advisers's CDTX Position: Q2 2024 in Review

Two Sigma Advisers sold out of Cidara Therapeutics (CDTX) in Q2 2024, closing a stake of 1,195 shares — an estimated $22K sold.

Two Sigma Advisers first reported a position in CDTX in Q4 2019 and held it in 18 quarters. The position peaked at $1.05M in Q3 2021. 26 funds tracked by Wall St. Rank hold CDTX as of Q2 2024.

  • Two Sigma Advisers reported no remaining Cidara Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 1,195 Cidara Therapeutics shares in Q2 2024, an estimated $22K.
  • Two Sigma Advisers first reported a position in Cidara Therapeutics in Q4 2019 and held it in 18 quarters.
  • Two Sigma Advisers's Cidara Therapeutics position peaked at $1.05M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.